What are the appropriate treatment options for intertrigo?

Treatment of Intertrigo

For uncomplicated intertrigo, begin with moisture control and barrier protection using topical agents; add topical antifungals (nystatin or azoles) if candidal infection is suspected or confirmed, and reserve low-potency topical corticosteroids for inflammatory cases without active infection.

Initial Assessment and Risk Factor Management

Identify and address predisposing factors immediately 1, 2:

• Obesity - encourage weight loss as primary intervention
• Diabetes mellitus - optimize glycemic control
• Local moisture and friction - from skin folds, occlusive clothing, or excessive sweating
• Immunosuppression - HIV, corticosteroid use, chemotherapy
• Poor hygiene or inability to maintain dry skin folds

Treatment Algorithm

Step 1: Basic Skin Fold Management (All Patients)

• Keep affected areas clean and completely dry
• Gently separate skin folds and allow air circulation
• Apply moisture-wicking textiles within skin folds to reduce friction 1
• Establish structured twice-daily skin care routine 1

Step 2: Determine Infection Status

For Candidal Intertrigo (most common infectious cause):

The 2016 IDSA guidelines note that superficial cutaneous candidiasis presents as intertrigo and rarely causes dissemination 3. However, the guidelines focus on systemic/invasive candidiasis rather than superficial intertrigo specifically.

Topical antifungal therapy 2:

• First-line: Nystatin cream/ointment OR azole antifungals (clotrimazole, miconazole, ketoconazole) applied twice daily
• Duration: 7-14 days minimum
• For recurrent cases: Consider treating intestinal colonization or periorificial infections 2
• For refractory cases with immunosuppression: Systemic azoles may be required 2

For Gram-Negative Bacterial Intertrigo (erosive, weeping, painful):

Most commonly caused by Pseudomonas aeruginosa (48% of cases) 4:

• Presents with fissures, exudates, and erosive lesions
• Often associated with eczema (52% of cases) 4
• Risk factors: psoriasis, vascular disease, prior fungal intertrigo, history of multiple failed treatments 4
• Treatment: Topical antibiotics targeting gram-negative organisms
• Expected duration: 56-61 days despite treatment 4
• Recurrence rate: 7-21% 4

Step 3: Address Inflammation

When to use topical corticosteroids:

• Inflammatory intertrigo without active infection
• Gram-negative bacterial intertrigo with associated eczema 4
• Agent: Low-potency corticosteroid (1% hydrocortisone) twice daily 5
• Duration: 2 weeks maximum to avoid skin atrophy and infection exacerbation
• Caution: Do NOT use with active candidal infection as this will worsen fungal overgrowth 5

Alternative anti-inflammatory options (if avoiding corticosteroids):

• Barrier sprays containing zinc gluconate-taurine complex with zinc oxide, panthenol, and glycerin showed significant reduction in erythema and pruritus at 15-30 days 6
• Adsorbent lotions with tapioca starch and botanical extracts demonstrated equivalent efficacy to 1% hydrocortisone with superior pruritus control 5

Common Pitfalls to Avoid

1. Using topical corticosteroids with active candidal infection - this creates a perfect environment for fungal proliferation
2. Inadequate drying between applications - moisture perpetuates the condition regardless of medication used
3. Stopping treatment too early - minimum 7-14 days needed even after clinical improvement
4. Ignoring underlying conditions - diabetes, obesity, and immunosuppression must be addressed or recurrence is inevitable 2
5. Overlooking denture-related candidiasis - if oral candidiasis present, disinfect dentures in addition to antifungal therapy 7

Special Populations

Immunocompromised patients (HIV, neutropenia, transplant):

• Higher risk of disseminated candidiasis from superficial infection 3
• Consider systemic antifungal therapy if extensive involvement or treatment failure 2
• The IDSA guidelines recommend aggressive evaluation of skin lesions in neutropenic patients as they may harbor resistant organisms, yeasts, or molds 3

Recurrent intertrigo:

• Investigate for intestinal candidal colonization 2
• Screen for undiagnosed diabetes mellitus
• Consider chronic suppressive therapy only if predisposing factors cannot be corrected 2

Monitoring and Follow-up

• Reassess at 2 weeks for treatment response
• If no improvement: obtain culture to identify specific pathogen and resistance patterns
• For gram-negative bacterial intertrigo: expect prolonged course (8-9 weeks) even with appropriate treatment 4
• Patient satisfaction and pruritus reduction are important quality-of-life outcomes 5, 6